Northumbria University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Newcastle United Kingdom (1992)

Organization Overview

First Clinical Trial
2005
NCT00487227
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Anklam Extrakt | Associate Director of the 'Brain, Performance and Nutrition Research Centre', Northumbria University, UK | Brain, Performance and Nutrition Research Centre - Northumbria University | david.kennedy@northumbria.ac.uk | Department of Sport, Exercise and Rehabilitation, University of Northumbria at Newcastle | Director of the 'Brain, Performance and Nutrition Research Centre', Northumbria University, UK | Javier Gonzalez, PhD | Northumbria University | Northumbria University Newcastle, UK | U. Northumbria, Brain Performance and Nutrition Research Centre, Department of Psychology

Active Ingredients

Drugs in Phase 4 Trials (7)

caffeine (4 trials)

guarana (1 trial)

l-epigallocatechin (1 trial)

multivitamins (2 trials)

theanine (1 trial)

vitamin c (3 trials)

vitamin q (2 trials)

Drugs in Phase 2 Trials (1)

cognivida (1 trial)

Drugs in Phase 1 Trials (2)

pomegranate extract (1 trial)

resveratrol (9 trials)

Drugs in Other Trials (45)

aminosyn ii (1 trial)

aronia extract (2 trials)

asparmate (1 trial)

Avena sativa (1 trial)

ballota nigra (1 trial)

berry polyphenols (3 trials)

blackberry juice (1 trial)

blueberry (1 trial)

brown seaweed (1 trial)

butter (1 trial)

calcium (3 trials)

cherry juice (2 trials)

coffee bean (1 trial)

crataegus (1 trial)

dha-enriched omega-3 polyunsaturated fatty acid (1 trial)

docosahexaenoic acid (2 trials)

efalex (2 trials)

eicosapentanoic acid (2 trials)

epa-enriched omega-3 polyunsaturated fatty acid (1 trial)

fish oil (Omegavan) (1 trial)

fresh berry extract (1 trial)

ginkgo biloba (1 trial)

glucose (2 trials)

hops extract (1 trial)

icosapent ethyl (vascepa) (3 trials)

insulin human (humulin) (2 trials)

iron bisglycinate (2 trials)

lactobacillus paracasei (1 trial)

maltodextrin (1 trial)

mangiferin (1 trial)

mentha piperita (1 trial)

montmorency cherry (4 trials)

olive oil (4 trials)

passiflora incarnata (1 trial)

polyphenols (1 trial)

polyunsaturated fatty acids (1 trial)

sage (1 trial)

sideritis scardica (1 trial)

silicon dioxide (1 trial)

sucrose (3 trials)

tivantinib (1 trial)

turmeric (1 trial)

whey protein (1 trial)

wild blueberry extract (1 trial)

zanthozylum armatum (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatigue (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 69
  • # of Trial APIs: 55